Acceptability and Feasibility of Simultaneous Screening for Viral Hepatitis B, C and HIV Among Drug Users and Vulnerable Populations, in Non-conventional Structures "Outside the Walls" by Dual Screening Method RTDs and FibroScan®

This study is testing whether a dual rapid screening approach — using quick finger-prick blood tests plus a liver stiffness scan (FibroScan) — can effectively identify hepatitis B, hepatitis C, and HIV in people who use drugs or are from vulnerable populations who may not typically access traditional healthcare settings. **You may be eligible if...** - You are 18 years old or older - You visit or are referred to a non-traditional community health setting (e.g., a harm reduction center or outreach service) - You have no objection to taking part in the research **You may NOT be eligible if...** - You are under 18 years old - You object to participating in research Talk to your doctor to see if this trial is right for you.